全面领“鲜”！飞鹤京东首发迹萃、启萃两大奶粉新品，引领鲜活营养革新

Core Viewpoint - Feihe has launched two innovative products, Jicui and Qicui, in collaboration with JD.com, marking a significant advancement in infant nutrition tailored for Chinese babies, leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][4]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing consumer demands for effective nutrient absorption, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [4]. - Feihe's innovation includes the first-ever integration of "freshness of raw materials" into the standards for infant formula, achieving a closed-loop system from fresh sources to self-produced active ingredients [4][6]. Group 2: Nutritional Advancements - Jicui and Qicui utilize a unique low-temperature extraction process from high-quality fresh milk, resulting in a 23-fold increase in freshness and a 6.4-fold improvement in nutrient absorption [6]. - The products are made from raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques enhancing the nutritional quality [6][11]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national research initiatives, accumulating significant findings that inform the development of their infant formula [12]. - The company emphasizes a holistic approach to nutrition, focusing on the synergistic effects of nutrients rather than merely increasing individual nutrient levels, effectively replicating the composition of breast milk [14]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials to validate the efficacy of Jicui and Qicui before their market release, ensuring high standards of evidence [21]. - Clinical results indicate that infants fed with Jicui show a 38% reduction in illness rates and a 40% improvement in recovery rates compared to conventional formulas, demonstrating superior immune support [22]. Group 5: Market Positioning - The launch of Jicui and Qicui represents not just a product upgrade but a commitment to providing formulas that are more suitable for Chinese infants, setting a new benchmark in the infant formula industry [22].